loanDepot, Inc. Receives NYSE Notice Over Sub-$1 Share Price

What Happened

• On August 21, 2026, loanDepot, Inc. announced it received a written notice from the New York Stock Exchange that its Class A common stock is not in compliance with Section 802.01C because the average closing price was below $1.00 over a consecutive 30 trading‑day period.
• The notice does not immediately affect the listing, the company’s business operations, or its SEC reporting obligations.

Key Details

• Notice date: August 21, 2026.
• Rule cited: NYSE Listed Company Manual Section 802.01C (minimum $1.00 average closing price over a 30 trading‑day period).
• Cure period: six months from receipt (through Feb 21, 2027); company can regain compliance before then if, on the last trading day of any calendar month in that period, the share price and 30‑day average are both at least $1.00.
• Administrative steps: loanDepot must notify the NYSE within 10 business days of its intent to cure; the company intends to do so. If a cure requires shareholder approval, that approval must be obtained by the next annual meeting and implemented promptly.
• The company attached a press release (Exhibit 99.1) to the 8‑K.

Why It Matters

• For investors, the notice signals a risk that loanDepot’s NYSE listing could be suspended and delisted if the company does not meet the $1.00 price criteria within the six‑month cure period.
• The filing is procedural and gives loanDepot time to restore its share price or pursue an approved remedy; it does not by itself change operations or financial reporting.